Author:
Mackenzie Gary D.,Dunn Jason M.,Selvasekar C. R.,Mosse C. Alexander,Thorpe Sally M.,Novelli Marco R.,Bown Stephen G.,Lovat Laurence B.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Newnham A, Quinn MJ, Babb P et al (2003) Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971–1998. Aliment Pharmacol Ther 17:665–676. doi: 10.1046/j.1365–2036.2003.01521.x
2. Montgomery E, Goldblum JR, Greenson JK et al (2001) Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32:379–388. doi: 10.1053/hupa.2001.23511
3. Reid BJ, Levine DS, Longton G et al (2000) Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95:1669–1676
4. Schnell TG, Sontag SJ, Chejfec G et al (2001) Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology 120:1607–1619. doi: 10.1053/gast.2001.25065
5. Overholt BF, Wang KK, Burdick JS et al (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 66:460–468. doi: 10.1016/j.gie.2006.12.037
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献